RAMYD Study - Evaluation of Arrhythmic Risk in Myotonic Dystrophy

Key facts

Sponsor

Catholic University of the Sacred Heart

Principal Investigator

Fulvio Bellocci, MD

Catholic University of Sacred Heart

Intervention

Electrophysiological study(procedure)

Enrollment

537 enrolled

Eligibility

18-70 years · All sexes

Timeline

2003 – 2010

Study locations (1)

• Catholic University of Sacred Heart, Rome, Italy

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Myotonic dystrophy

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE3NCT07486934
  Efficacy, Safety, and Tolerability of DYNE-101 in Participants With Myotonic Dystrophy Type 1
  Dyne Therapeutics
• RECRUITINGPHASE2NCT07220603
  An Open-Label Extension Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 (FREEDOM-OLE)
  PepGen Inc
• ACTIVE NOT RECRUITINGNCT07493525
  Fall Frequency and Factors Affecting Dynamic Balance in Patients With Myotonic Dystrophy Type 1
  Antalya Training and Research Hospital
• RECRUITINGNCT06747884
  Trial Readiness and Endpoint Assessment in Pediatric Myotonic Dystrophy Extension
  Virginia Commonwealth University
• RECRUITINGNCT07385443
  The Spanish National Registry for Myotonic Dystrophy Type 1
  Fundació Institut Germans Trias i Pujol
• RECRUITINGNCT07362875
  Development of Quantitative Muscle Imaging as a Biomarker of Disease Endpoints in Myotonic Dystrophy
  Wake Forest University Health Sciences
• RECRUITINGNANCT06809049
  Music Intervention for Brain-Heart Disease in Myotonic Dystrophy Type 1 (DM1)
  Hanns Lochmuller
• RECRUITINGPHASE2NCT06667453
  A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1
  PepGen Inc

See all trials for Myotonic dystrophy →